The US market for oncology drugs was estimated to be worth USD 150.2 billion in 2023. From 2024 to 2030, the total revenue from oncology drugs in the US is projected to grow at a compound annual growth rate (CAGR) of 15.51%, or close to USD 412.2 billion. The extensive report offers a thorough examination of the robust US oncology drugs market. MMR has thoughtfully analyzed the history of...